3060
T. A. Moss, T. Nowak / Tetrahedron Letters 53 (2012) 3056–3060
Prep. Proced. Int. 2001, 33, 411; (d) Sundberg, R. J In Comprehensive Heterocyclic
Chemistry; Katritzky, A. R., Rees, C. W., Scriven, E. F. V., Eds.; Vol. 2; Pergamon:
Oxford, 1996; p p 119.
group in all of these products could be readily removed with HCl in
1,4-dioxane.
In conclusion, we have shown that a three-component, one-pot
Hantzsch approach can give pyrroles and furans bearing differen-
tially reactive carbonyl moieties at the 2- and 3-positions, a hith-
erto challenging substitution pattern to access.16 Keto-nitrile
compound 4 reacted with a range of halo-carbonyls to give bis-,
tri- and polysubstituted pyrroles in reasonable yields. Interest-
ingly, its ester analogue 8 formed the corresponding furan, proba-
bly through a Feist–Bénary type mechanism. As demonstrated, the
products contain several handles for further manipulation and
thus, this method should find use in total synthesis and medicinal
chemistry campaigns.
5. (a) Roomi, M. W.; MacDonald, S. F. Can. J. Chem. 1970, 48, 1689; (b)Angew.
Chem., Int. Ed. 1999, 38, 2896; (c) Palacios, F.; Aparicio, D.; De los Santos, J. M.;
Vicario, J. Tetrahedron 1961, 2001, 57.
6. For examples, see: (a) Trost, B. M.; Doherty, G. A. J. Am. Chem. Soc. 2000, 122,
3801; (b) Tracey, M. R.; Hsung, R. P.; Lambeth, R. H. Synthesis 2004, 918.
7. Trautwein, A. W.; Süssmuth, R. D.; Jung, G. Bioorg. Med. Chem. Lett. 1998, 8,
2381.
8. Murthy, S. N.; Madhav, B.; Kumar, A. V.; Rao, K. R.; Nageswar, Y. V. D. Helv.
Chim. Acta 2009, 92, 2118.
9. For examples, see: (a) Röder, E.; Wiedenfeld, H.; Bourael, T. Liebigs Ann. Chem.
1987, 1117; (b) Boëlle, J.; Schneider, R.; Gérardin, P.; Loubinoux, B. Synthesis
1997, 1451.
10. Schmuck, C.; Rupprecht, D. Synthesis 2007, 3095.
11. Bellamy, F.; Martz, P.; Streith, J. Heterocycles 1975, 3, 395.
12. Thyrann, T.; Lightner, D. A. Tetrahedron Lett. 1995, 36, 4345.
13. (a) Brittain, J. M.; Jones, R. A.; Jones, R. O.; King, T. J. J. Chem. Soc., Perkin Trans. 1
1981, 2656; (b) Paine, J. B. III.; Dolphin, D. J. Org. Chem. 1988, 53, 2787.
14. Bloch, R. Ann. Chim. (Paris) 1965, 10, 583.
References and notes
1. For examples, see: (a) Boger, D. L.; Boyce, C. W.; Labroli, M. A.; Sehon, C. A.; Jin,
Q. J. Am. Chem. Soc. 1999, 121, 54; (b) Fürstner, A. Angew. Chem., Int. Ed. 2003,
42, 3582; (c) O’Malley, D. P.; Li, K.; Maue, M.; Zografos, A. L.; Baran, P. S. J. Am.
Chem. Soc. 2007, 129, 4762.
15. For the original reports, see: (a) Feist, F. Chem. Ber. 1902, 35, 1537; (b) Bénary,
E. Chem. Ber. 1911, 44, 489; For an example of an asymmetric ‘interrupted’
Feist–Bénary synthesis, where an intermediate such as 10 is obtained, see: (c)
Calter, M. A.; Phillips, R. M.; Flaschenriem, C. J. Am. Chem. Soc. 2005, 127, 14566.
16. Representative procedure for the synthesis of 1: Enolate 4 (485 mg, 2.5 mmol)
was stirred in EtOH (12 mL) with NH4OAc (578 mg, 7.5 mmol). After 5 min the
solids had fully dissolved. At this point, chloroacetylaldehyde (50% in H2O,
0.48 mL, 3.75 mmol) was added and the reaction was warmed to 80 °C for 1 h.
Following cooling to room temperature, AcOH–H2O (4:1, 10 mL) was added
and stirring was continued for 30 min. The volatiles were removed under
vacuum and the residue was dissolved in CH2Cl2 and washed with H2O. The
aqueous was extracted once with CH2Cl2, and the combined organics were
dried over Na2SO4 and concentrated. The dark residue was purified by silica gel
chromatography [heptane/EtOAc, 9:1–3:1] to give 2-formylpyrrole-3-
carbonitrile (1) as an off-white solid, 153.5 mg, 51%. Mp 146–148 °C; mmax
(cmÀ1) 2995 (w), 2235 (w), 1685 (s), 1410 (w), 1360 (s), 1185 (m); 1H NMR
(400 MHz, CDCl3] 6.68 (t, 1H, J = 2.7, CHPyrrole), 7.15 (td, 1H, J = 1.0, 2.8,
CHPyrrole), 9.81 (d, 1H, J = 1.0, CHAldehyde), 10.03 (br s, 1H, NH); 13C NMR
(100 MHz, DMSO-d6) 98.73 (CAr), 114.72 (CN), 115.09 (CHAr), 126.58 (CHAr),
135.36 (CAr), 177.99 (CHO); m/z (EI) 120 [(M+H)+, 100%)], 92 (45), 64 (25);
HRMS (EI) [M+H]+ 120.0392, C6H4N2O requires 120.0324.
2. In antibacterials: (a) Hughes, C. C.; Prieto-Davo, A.; Jensen, P. R.; Fenical, W. Org.
Lett. 2008, 10, 629; In antibiotics: (b) Williamson, N. R.; Simonsen, H. T.;
Ahmed, R. A. A.; Goldet, G.; Slater, H.; Woodley, L.; Leeper, F. J.; Salmond, G. P. C.
Mol. Microbiol. 2005, 56, 971; In antitubercular: (c) Protopopova, M.;
Bogatcheva, E.; Nikonenko, B.; Hundert, S.; Einck, L.; Nacy, C. L. Med. Chem.
2007, 3, 301; In HIV therapies: (d) Teixeira, C.; Barbault, F.; Rebehmed, J.; Liu,
K.; Xie, L.; Lu, H.; Jiang, S.; Fan, B.; Maurel, F. Bioorg. Med. Chem. 2008, 16, 3039.
3. (a) Groenendaal, L.; Meijer, E.-W.; Vekemans, J. A. J. M. In Electronic Materials:
The Oligomer Approach; Müllen, K., Wenger, G., Eds.; Wiley-VCH; Weinheim,
1997; (b) Domingo, V. M.; Aleman, C.; Brillas, E.; Julia, L. J. Org. Chem. 2001, 66,
4058; In semiconducting materials: (c) Lazerges, M.; Chane-Ching, K. I.;
Aeiyach, S.; Chelli, S.; Peppin-Donnat, B.; Billon, M.; Lombard, C.; Maurel, F.;
Jouini, M. J. Solid State Electrochem. 2009, 13, 231; In glucose sensors: (d) Kros,
A.; van Hövel, S. W. F. M.; Nolte, R. J. M.; Sommerdijk, N. A. J. M. Sens. Actuators,
B 2001, 80, 229.
4. For reviews, see: (a) Estévez, V.; Villacampa, M.; Menéndez, J. C. Chem. Soc. Rev.
2010, 39, 4402; (b) Balme, G. Angew. Chem., Int. Ed. 2004, 43, 6238; (c) Ferreira,
V. F.; de Souza, M. C. B. V.; Cunha, A. C.; Pereira, L. O. R.; Ferreira, M. L. G. Org.